Home LiteratureArticle Details
PMID: 12620891 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Activation of gene expression in human neutrophils by high mobility group box 1 protein.

American journal of physiology. Cell physiology ·Vol. 284 ·No. 4 ·2003-04-00 ·Pages C870-9

Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E

Abstract

High mobility group box 1 (HMGB1) protein, a DNA binding protein that stabilizes nucleosomes and facilitates transcription, was recently identified as a late mediator of endotoxin lethality. High serum HMGB1 levels in patients with sepsis are associated with increased mortality, and administration of HMGB1 produces acute inflammation in animal models of lung injury and endotoxemia. Neutrophils occupy a critical role in mediating the development of endotoxemia-associated acute lung injury, but previously it was not known whether HMGB1 could influence neutrophil activation. In the present experiments, we demonstrate that HMGB1 increases the nuclear translocation of NF-kappaB and enhances the expression of proinflammatory cytokines in human neutrophils. These proinflammatory effects of HMGB1 in neutrophils appear to involve the p38 MAPK, phosphatidylinositol 3-kinase/Akt, and ERK1/2 pathways. The mechanisms of HMGB1-induced neutrophil activation are distinct from endotoxin-induced signals, because HMGB1 leads to a different profile of gene expression, pattern of cytokine expression, and kinetics of p38 activation compared with LPS. These findings indicate that HMGB1 is an effective stimulus of neutrophil activation that can contribute to development of a proinflammatory phenotype in diseases characterized by excessively high levels of HMGB1.

MeSH Terms
Biological Transport/drug effects Cells, Cultured Chemokines/genetics Cytokines/genetics Enzyme Activation/drug effects Enzyme Inhibitors/pharmacology Gene Expression/drug effects,physiology HMGB1 Protein/pharmacology,physiology Humans Inflammation Mediators/physiology Lipopolysaccharides/pharmacology Mitogen-Activated Protein Kinases/antagonists & inhibitors NF-kappa B/metabolism Neutrophils/drug effects,physiology Phosphoinositide-3 Kinase Inhibitors Phosphotransferases/metabolism RNA, Messenger/metabolism p38 Mitogen-Activated Protein Kinases
Chemicals
Chemokines Cytokines Enzyme Inhibitors HMGB1 Protein Inflammation Mediators Lipopolysaccharides NF-kappa B Phosphoinositide-3 Kinase Inhibitors RNA, Messenger Phosphotransferases Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Park Jong Sung
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Arcaroli John
Yum Ho-Kee
Yang Huan
Wang Haichao
Yang Kuang-Yao
Choe Kang-Hyeon
Strassheim Derek
Pitts Todd M
Tracey Kevin J
Abraham Edward
Article Info
Journal
American journal of physiology. Cell physiology
Abbr.
Am J Physiol Cell Physiol
ISSN
0363-6143
Published
2003-04-00
Pages
C870-9
Language
English
Region
United States
NLM ID
100901225
Subset
IM
Grants
NHLBI NIH HHS · 1-P01-HL-068743 · United States
NHLBI NIH HHS · HL-62221 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]